Sollis Therapeutics
Columbus, US · Founded 2017
Biotech
Founders & leadership
AD
Alex DiNelloExecutive Officer
Reported raises · per SEC filings
Form D private placements$2.5MraisedMar 2021 · 2 investors · Biotechnology
Rule 506(c)$2.5MraisedAug 2020 · 3 investors · Biotechnology
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.